Why Nostr? What is Njump?
2025-03-29 15:02:18
in reply to

The Gateway Pundit - by layer3.news on Nostr: The Gateway Pundit ✍️ The article discusses the evolution of GLP-1 receptor ...



✍️ The article discusses the evolution of GLP-1 receptor agonists and their expanding role beyond diabetes treatment, highlighting the potential of retatrutide and the oral formula DROP for weight management.
👉 GLP-1 receptor agonists have evolved from treating type 2 diabetes to addressing weight loss and metabolic health
👉 Retatrutide is a triple-receptor agonist that targets GLP-1, GIP, and glucagon receptors
👉 DROP is an oral retatrutide formula that provides a non-injectable solution for weight management and metabolic health

#Dr.PeterMcCullough #health


Dr. Peter McCullough examines the transformative journey of GLP-1 receptor agonists, highlighting the promising future of retatrutide. This post delves into innovative treatment options that could redefine weight management. The post Dr. McCullough Weighs In: The History & Future of GLP-1s appeared first on The Gateway Pundit.
https://www.thegatewaypundit.com/2025/03/dr-mccullough-weighs-history-future-glp-1s/

Author Public Key
npub1sd38mc83fmnh9yv4xu4w56t3p8pwzjhxc60urtc24gkdqtc7qecsrswl5w